Description
Pre-packaged rAAV in Serotype-DJ, constitutively express TCR recognizing CD1a-galactosylceramide (GalCer) (Clone: NKT15), under a enhanced CMV Promoter (which is tested strong in T cells and B cells). See Product Manual for details.
This TCR construct (Click to see its sequence, from Clone NKT15) express the antibody specifically recognizes the lipid-based antigen, α-galactosylceramide (α-GalCer) (presented by CD1d). It is often used to engineer invariant natural killer T (iNKT) cells.
The TCR α chain variable region with a transmembrane (TM) domain is linked with TCR β chain variable region with a transmembrane (TM) domain, by F2A element, as “TCRα(V)/Tm-F2A-TCRβ(V)/Tm”. The following scheme showed the AAV vector’s core structure.
Significant strides have been made in T cell therapies targeting well-characterized tumor antigens, including CD19 / CD20, CD22, Her2, BCMA HLA-A2, TGFβ specific-CAR. Please see also Gentartet’s CAR-T Lentivirus product, click CAR-T Lentivirus Manual, and click Anti-CD19 CAR-T Manual to see all products. Please also look at our TCR Lentivirus page. Note: all products are for research use ONLY.
AAV Serotype-DJ is a synthetic serotype made from different serotypes using DNA shuffling. AAV-DJ serotype has the enhanced transduction efficiency in vitro and in vivo compared to wild-type serotypes with Broad Cell Tropism, great transduction rate in CNS, Liver, Kidney, Fibroblasts, muscle.
Titer: ~ 1×10^12 GC/mL
Size: 100ul/vial, in stock, ready to ship in overnight Dry-ice package.
Storage Buffer: PBS
CAT#: A52.DJ
